Literature DB >> 8110804

Polymorphism in stratum corneum lipids.

B Ongpipattanakul1, M L Francoeur, R O Potts.   

Abstract

Fourier transform infrared spectroscopy (FTIR) was employed to investigate the thermotropic phase behavior of stratum corneum lipid multilamellae. Stratum corneum (SC), the uppermost layer of mammalian skin, is unusual in many respects. It has been demonstrated that the lipids of the stratum corneum provide the primary electrical and transport resistance in the skin. These lipids are unusual in their composition, structure and localization; they contain only cholesterol, fatty acids and ceramides and they form broad, multi-lamellar sheets which are located extracellularly. The FTIR results from both the symmetric CH2 stretching and the CH2 scissoring vibrations suggest that the SC lipids exhibit polymorphic phase behavior below the main phase transition temperature. The multiple phases are most likely crystalline mixtures of different alkyl chain packings, along with solid-liquid phases. Similarities between the FTIR results reported here for SC lipids and those obtained for cholesterol-containing gel phase phospholipids suggest that the non-uniform distribution of cholesterol occurs in each system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8110804     DOI: 10.1016/0005-2736(94)90040-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  Chemical uptake into human stratum corneum in vivo from volatile and non-volatile solvents.

Authors:  A L Stinchcomb; F Pirot; G D Touraille; A L Bunge; R H Guy
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

2.  Direct observation of domains in model stratum corneum lipid mixtures by Raman microspectroscopy.

Authors:  A Percot; M Lafleur
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

3.  Molecular dynamics and partitioning of di-tert-butyl nitroxide in stratum corneum membranes: effect of terpenes.

Authors:  Heverton Silva Camargos; Adolfo Henrique Moraes Silva; Jorge Luiz Vieira Anjos; Antonio Alonso
Journal:  Lipids       Date:  2010-04-02       Impact factor: 1.880

4.  Imaging the distribution of sodium dodecyl sulfate in skin by confocal Raman and infrared microspectroscopy.

Authors:  G Mao; C R Flach; R Mendelsohn; R M Walters
Journal:  Pharm Res       Date:  2012-04-04       Impact factor: 4.200

5.  Simulation study of the structure and phase behavior of ceramide bilayers and the role of lipid head group chemistry.

Authors:  Shan Guo; Timothy C Moore; Christopher R Iacovella; L Anderson Strickland; Clare McCabe
Journal:  J Chem Theory Comput       Date:  2013-11-12       Impact factor: 6.006

6.  Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients.

Authors:  Michelle Janssens; Jeroen van Smeden; Gert S Gooris; Wim Bras; Guiseppe Portale; Peter J Caspers; Rob J Vreeken; Thomas Hankemeier; Sanja Kezic; Ron Wolterbeek; Adriana P Lavrijsen; Joke A Bouwstra
Journal:  J Lipid Res       Date:  2012-09-28       Impact factor: 5.922

7.  Cholesterol sulfate and Ca(2+) modulate the mixing properties of lipids in stratum corneum model mixtures.

Authors:  Marjolaine Arseneault; Michel Lafleur
Journal:  Biophys J       Date:  2006-10-06       Impact factor: 4.033

8.  Effects of omega-O-acylceramide structures and concentrations in healthy and diseased skin barrier lipid membrane models.

Authors:  Lukáš Opálka; Andrej Kováčik; Petra Pullmannová; Jaroslav Maixner; Kateřina Vávrová
Journal:  J Lipid Res       Date:  2019-12-19       Impact factor: 5.922

9.  Effects of sucrose oleate and sucrose laureate on in vivo human stratum corneum permeability.

Authors:  Hilda A Ayala-Bravo; David Quintanar-Guerrero; Aarti Naik; Yogeshvar N Kalia; José M Cornejo-Bravo; Adriana Ganem-Quintanar
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

10.  Phase properties of mixtures of ceramides.

Authors:  C H Han; R Sanftleben; T S Wiedmann
Journal:  Lipids       Date:  1995-02       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.